메뉴 건너뛰기




Volumn 2, Issue 12, 2004, Pages 2276-2277

More on: Is laboratory monitoring of low-molecular-weight heparin necessary? [10]

Author keywords

[No Author keywords available]

Indexed keywords

DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN;

EID: 13244289978     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00988.x     Document Type: Letter
Times cited : (13)

References (8)
  • 1
    • 3242734130 scopus 로고    scopus 로고
    • Is laboratory monitoring of low-molecular-weight heparin therapy necessary? Yes
    • Harenberg J. Is laboratory monitoring of low-molecular-weight heparin therapy necessary? Yes. J Thromb Haemost 2004; 2: 547-50.
    • (2004) J. Thromb. Haemost. , vol.2 , pp. 547-550
    • Harenberg, J.1
  • 2
    • 3242678141 scopus 로고    scopus 로고
    • Is laboratory monitoring of low-molecular-weight heparin therapy (LMWH) necessary?
    • Bounameaux H. de Moerloose P. Is laboratory monitoring of low-molecular-weight heparin therapy (LMWH) necessary? J Thromb Haemost 2004; 2: 551-4.
    • (2004) J. Thromb. Haemost. , vol.2 , pp. 551-554
    • Bounameaux, H.1    de Moerloose, P.2
  • 3
    • 0031680310 scopus 로고    scopus 로고
    • College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy. The clinical use and laboratory monitoring of low-molecular weight heparin, danaparoid, hirudin and related compounds, and argatroban
    • Laposata M, Green D, Van Cott EM, Barrowcliffe TW, Goodnight SH, Sosolik RC. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy. The clinical use and laboratory monitoring of low-molecular weight heparin, danaparoid, hirudin and related compounds, and argatroban. Arch Pathol Lab Med 1998; 122: 799-807.
    • (1998) Arch. Pathol. Lab. Med. , vol.122 , pp. 799-807
    • Laposata, M.1    Green, D.2    Van Cott, E.M.3    Barrowcliffe, T.W.4    Goodnight, S.H.5    Sosolik, R.C.6
  • 4
    • 0029929402 scopus 로고    scopus 로고
    • Low-molecular-weight heparin in pediatric patients with thrombotic disease: A dose finding study
    • Massicotte P, Adams M, Brooker LA, Andrew M. Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr 1996; 128: 313-8.
    • (1996) J. Pediatr. , vol.128 , pp. 313-318
    • Massicotte, P.1    Adams, M.2    Brooker, L.A.3    Andrew, M.4
  • 6
    • 0029049674 scopus 로고
    • Low molecular weight heparin(s)
    • Barrowcliffe TW. Low molecular weight heparin(s). Br J Haematol 1995; 90: 1-7.
    • (1995) Br. J. Haematol. , vol.90 , pp. 1-7
    • Barrowcliffe, T.W.1
  • 7
    • 0032883549 scopus 로고    scopus 로고
    • Anti Xa monitoring during treatment with low-molecular-weight heparin or danaparoid: Inter-assay variability
    • Kitchen S, Iampietro R, Woolley AM, Preston FE. Anti Xa monitoring during treatment with low-molecular-weight heparin or danaparoid: inter-assay variability. Thromb Haemost 1999; 82: 1289-93.
    • (1999) Thromb. Haemost. , vol.82 , pp. 1289-1293
    • Kitchen, S.1    Iampietro, R.2    Woolley, A.M.3    Preston, F.E.4
  • 8
    • 13244290855 scopus 로고    scopus 로고
    • CG2-B. Coagulation booklet
    • CAP. Northfield, IL: College of American Pathologists
    • CAP. CAP Surveys. CG2-B. Coagulation booklet. Northfield, IL: College of American Pathologists, 2004: 34.
    • (2004) CAP Surveys , pp. 34


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.